ZV

Zephyr Venture Partners

North America, British Columbia, Canada, Vancouver

Description

Biotech/pharma/healthcare

Investor Profile

Zephyr Venture Partners has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Pre Seed, Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Sales, Biotechnology, Health Care.

Stage Focus

  • Pre Seed (50%)
  • Convertible Note (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Sales
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zephyr Venture Partners frequently co-invest with?

Natural Capital
North America, California, United States, Palo Alto
Co-Investments: 1
FAST — by GETTYLAB
North America, California, United States, San Francisco
Co-Investments: 1
Helios Capital
North America, New York, United States, New York
Co-Investments: 1
Sand Hill Angels
North America, California, United States, Mountain View
Co-Investments: 1
Plum Alley
North America, New York, United States, New York
Co-Investments: 1
Tribe Capital
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Zephyr Venture Partners often collaborate with?

PD
North America, California, United States, Menlo Park
Shared Deals: 1
AM
North America, California, United States, San Francisco
Shared Deals: 1
KA
North America, California, United States, San Francisco
Shared Deals: 1
BG
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
SD
North America, California, United States, San Francisco
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Zephyr Venture Partners?

Default

San Francisco, California, United States

Default is an all-in-one inbound lead qualification, scheduling, & routing platform.

Sales
Pre SeedOct 1, 2021
Amount Raised: $700,000
Ashvattha Therapeutics

Redwood City, California, United States

Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Convertible NoteMay 31, 2020
Amount Raised: $22,000,000

Find More Investors Like Zephyr Venture Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Zephyr Venture Partners | Pipeseed